The recipient of gene-edited islets to evade the immune system is making insulin without the use of immunusuppresives.| Breakthrough T1D
Hypoimmune (HIP) islets are making insulin, without immunosuppressants, in the first person treated with type 1 diabetes.| Breakthrough T1D
170 Delegates with type 1 diabetes (T1D) traveled to Washington, D.C. for the Breakthrough T1D 2025 Children's Congress.| Breakthrough T1D